Barbara Marie O'Brien, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 11 | 2023 | 1274 | 1.590 |
Why?
|
| Fetofetal Transfusion | 10 | 2015 | 116 | 1.010 |
Why?
|
| Genetic Counseling | 3 | 2018 | 634 | 0.920 |
Why?
|
| Fetal Diseases | 5 | 2014 | 916 | 0.890 |
Why?
|
| Aneuploidy | 6 | 2023 | 573 | 0.840 |
Why?
|
| DNA | 7 | 2017 | 7214 | 0.650 |
Why?
|
| Fetoscopy | 7 | 2014 | 138 | 0.620 |
Why?
|
| Rh Isoimmunization | 1 | 2018 | 23 | 0.610 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 606 | 0.600 |
Why?
|
| Genetics | 1 | 2018 | 114 | 0.580 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2017 | 59 | 0.540 |
Why?
|
| Laser Therapy | 8 | 2014 | 1110 | 0.540 |
Why?
|
| Genetic Testing | 7 | 2018 | 3590 | 0.510 |
Why?
|
| Dendrites | 1 | 2017 | 472 | 0.480 |
Why?
|
| Certification | 1 | 2018 | 420 | 0.480 |
Why?
|
| Pamphlets | 2 | 2014 | 71 | 0.470 |
Why?
|
| Pregnancy | 34 | 2024 | 30175 | 0.440 |
Why?
|
| Nociceptors | 1 | 2017 | 460 | 0.440 |
Why?
|
| HLA Antigens | 1 | 2018 | 1336 | 0.410 |
Why?
|
| Emotions | 1 | 2023 | 2768 | 0.380 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2011 | 62 | 0.360 |
Why?
|
| Quadruplets | 1 | 2010 | 9 | 0.350 |
Why?
|
| Communication | 2 | 2023 | 3908 | 0.350 |
Why?
|
| Foodborne Diseases | 1 | 2010 | 41 | 0.350 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1181 | 0.340 |
Why?
|
| Blood Component Removal | 1 | 2011 | 132 | 0.340 |
Why?
|
| Transplantation | 1 | 2010 | 221 | 0.310 |
Why?
|
| ABO Blood-Group System | 1 | 2011 | 381 | 0.300 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2008 | 22 | 0.300 |
Why?
|
| Twins | 1 | 2009 | 340 | 0.290 |
Why?
|
| Placenta | 6 | 2019 | 1721 | 0.290 |
Why?
|
| Selection Bias | 1 | 2008 | 360 | 0.260 |
Why?
|
| Trisomy | 4 | 2017 | 260 | 0.250 |
Why?
|
| Facies | 1 | 2024 | 224 | 0.220 |
Why?
|
| Hydrops Fetalis | 1 | 2023 | 113 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2018 | 4859 | 0.200 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2017 | 735 | 0.200 |
Why?
|
| Postpartum Hemorrhage | 1 | 2006 | 273 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 6 | 2024 | 1767 | 0.190 |
Why?
|
| Abnormalities, Multiple | 3 | 2024 | 1423 | 0.190 |
Why?
|
| Erythrocytes | 1 | 2011 | 2421 | 0.190 |
Why?
|
| Chromosome Disorders | 3 | 2014 | 499 | 0.180 |
Why?
|
| Diseases in Twins | 2 | 2015 | 447 | 0.170 |
Why?
|
| Fetus | 6 | 2019 | 1882 | 0.170 |
Why?
|
| Informed Consent | 2 | 2017 | 1010 | 0.160 |
Why?
|
| Female | 43 | 2024 | 397464 | 0.150 |
Why?
|
| Pregnancy Outcome | 6 | 2019 | 2957 | 0.150 |
Why?
|
| Oxytocics | 2 | 2011 | 67 | 0.150 |
Why?
|
| Health Promotion | 1 | 2010 | 2210 | 0.150 |
Why?
|
| Antigens, Human Platelet | 1 | 2018 | 41 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2714 | 0.150 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2018 | 64 | 0.150 |
Why?
|
| Pregnancy Complications | 4 | 2014 | 2965 | 0.150 |
Why?
|
| Relaxin | 1 | 2017 | 42 | 0.140 |
Why?
|
| Peripartum Period | 1 | 2018 | 137 | 0.140 |
Why?
|
| Hong Kong | 1 | 2017 | 170 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 4053 | 0.130 |
Why?
|
| Placenta Diseases | 1 | 2019 | 199 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 183 | 0.130 |
Why?
|
| Karyotyping | 4 | 2014 | 1177 | 0.130 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2014 | 137 | 0.130 |
Why?
|
| Premature Birth | 2 | 2023 | 1814 | 0.130 |
Why?
|
| Fetal Death | 3 | 2019 | 434 | 0.130 |
Why?
|
| Counseling | 1 | 2023 | 1554 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2017 | 577 | 0.120 |
Why?
|
| Early Detection of Cancer | 3 | 2015 | 3238 | 0.120 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 301 | 0.120 |
Why?
|
| Embryo Transfer | 1 | 2019 | 527 | 0.120 |
Why?
|
| Humans | 50 | 2024 | 768887 | 0.120 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2014 | 13 | 0.120 |
Why?
|
| Oxytocin | 2 | 2011 | 403 | 0.120 |
Why?
|
| Mosaicism | 2 | 2014 | 481 | 0.110 |
Why?
|
| Prader-Willi Syndrome | 1 | 2014 | 79 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.110 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2019 | 523 | 0.110 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 508 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 344 | 0.100 |
Why?
|
| Pregnant Women | 1 | 2017 | 571 | 0.100 |
Why?
|
| Angelman Syndrome | 1 | 2014 | 139 | 0.100 |
Why?
|
| Twins, Monozygotic | 1 | 2014 | 472 | 0.100 |
Why?
|
| Ethics, Medical | 1 | 2017 | 785 | 0.100 |
Why?
|
| Quality Control | 1 | 2015 | 836 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2014 | 640 | 0.100 |
Why?
|
| Sigmoidoscopy | 1 | 2012 | 150 | 0.100 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 279 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2024 | 12174 | 0.090 |
Why?
|
| Delivery, Obstetric | 2 | 2011 | 950 | 0.090 |
Why?
|
| Mass Screening | 4 | 2017 | 5455 | 0.090 |
Why?
|
| Prenatal Care | 2 | 2017 | 1159 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2017 | 848 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 880 | 0.090 |
Why?
|
| Midwifery | 1 | 2012 | 130 | 0.090 |
Why?
|
| United States Department of Agriculture | 1 | 2010 | 47 | 0.090 |
Why?
|
| Hemoglobinometry | 1 | 2010 | 35 | 0.090 |
Why?
|
| Pitch Perception | 1 | 2011 | 101 | 0.090 |
Why?
|
| Ischemia | 1 | 2019 | 1900 | 0.090 |
Why?
|
| Food Handling | 1 | 2010 | 158 | 0.080 |
Why?
|
| Misoprostol | 1 | 2011 | 94 | 0.080 |
Why?
|
| Geniculate Bodies | 1 | 2011 | 159 | 0.080 |
Why?
|
| Spectrophotometry | 1 | 2010 | 292 | 0.080 |
Why?
|
| Stillbirth | 1 | 2012 | 376 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 1390 | 0.080 |
Why?
|
| Digital Rectal Examination | 1 | 2009 | 42 | 0.080 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2009 | 65 | 0.080 |
Why?
|
| Down Syndrome | 2 | 2017 | 919 | 0.080 |
Why?
|
| Auditory Pathways | 1 | 2011 | 238 | 0.080 |
Why?
|
| Chromosome Aberrations | 2 | 2012 | 1780 | 0.080 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2013 | 503 | 0.080 |
Why?
|
| Blood Donors | 1 | 2011 | 344 | 0.080 |
Why?
|
| Congenital Abnormalities | 2 | 2015 | 703 | 0.080 |
Why?
|
| Anxiety | 1 | 2023 | 4677 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2017 | 1469 | 0.080 |
Why?
|
| Focus Groups | 2 | 2014 | 1461 | 0.070 |
Why?
|
| Pre-Eclampsia | 1 | 2017 | 1251 | 0.070 |
Why?
|
| Adult | 17 | 2024 | 223818 | 0.070 |
Why?
|
| Laser Coagulation | 1 | 2010 | 333 | 0.070 |
Why?
|
| Nursing Research | 1 | 2008 | 80 | 0.070 |
Why?
|
| Audiovisual Aids | 1 | 2008 | 99 | 0.070 |
Why?
|
| Amnion | 1 | 2008 | 202 | 0.070 |
Why?
|
| Auditory Cortex | 1 | 2011 | 365 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1189 | 0.070 |
Why?
|
| Ergonovine | 1 | 2006 | 14 | 0.070 |
Why?
|
| Maternal Health Services | 1 | 2012 | 470 | 0.070 |
Why?
|
| Labor Stage, Third | 1 | 2006 | 4 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 240 | 0.070 |
Why?
|
| Gynecology | 1 | 2012 | 534 | 0.070 |
Why?
|
| Erythropoietin | 1 | 2011 | 718 | 0.070 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 997 | 0.070 |
Why?
|
| Colorectal Neoplasms | 3 | 2015 | 6982 | 0.060 |
Why?
|
| Twinning, Monozygotic | 2 | 2015 | 17 | 0.060 |
Why?
|
| Obstetrics | 1 | 2012 | 678 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2006 | 398 | 0.060 |
Why?
|
| Chorion | 2 | 2015 | 112 | 0.060 |
Why?
|
| Hypotrichosis | 1 | 2024 | 7 | 0.060 |
Why?
|
| Amniotic Fluid | 1 | 2007 | 381 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2019 | 26394 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 2181 | 0.060 |
Why?
|
| Problem-Based Learning | 1 | 2008 | 360 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2015 | 2597 | 0.060 |
Why?
|
| Foot Deformities, Congenital | 1 | 2024 | 59 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2339 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3811 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2742 | 0.050 |
Why?
|
| Antibodies | 1 | 2011 | 2422 | 0.050 |
Why?
|
| Sacrum | 1 | 2024 | 275 | 0.050 |
Why?
|
| Syndrome | 2 | 2023 | 3274 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 11229 | 0.050 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 4919 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7885 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9618 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2023 | 576 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 2 | 2015 | 1737 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11934 | 0.040 |
Why?
|
| Endoscopy | 1 | 2009 | 1862 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2014 | 1836 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 2487 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 4568 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14751 | 0.040 |
Why?
|
| Young Adult | 4 | 2018 | 60110 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 311 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1602 | 0.030 |
Why?
|
| Inhibins | 1 | 2017 | 210 | 0.030 |
Why?
|
| Microsurgery | 2 | 1980 | 803 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2017 | 340 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6320 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3709 | 0.030 |
Why?
|
| Blastocyst | 1 | 2019 | 433 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2019 | 655 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8758 | 0.030 |
Why?
|
| United States | 6 | 2015 | 73180 | 0.030 |
Why?
|
| Germany | 1 | 2017 | 883 | 0.030 |
Why?
|
| Knowledge | 1 | 2017 | 178 | 0.030 |
Why?
|
| Live Birth | 1 | 2019 | 516 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1979 | 779 | 0.030 |
Why?
|
| Fetal Therapies | 1 | 2015 | 101 | 0.030 |
Why?
|
| Risk Factors | 4 | 2019 | 74971 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 124 | 0.030 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 273 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2019 | 733 | 0.030 |
Why?
|
| Fetal Heart | 1 | 2015 | 281 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 300 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 13593 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 463 | 0.030 |
Why?
|
| Sigmoidoscopes | 1 | 2012 | 5 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 9213 | 0.030 |
Why?
|
| Physician-Nurse Relations | 1 | 2012 | 20 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 474 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2012 | 15889 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 3 | 1980 | 1515 | 0.020 |
Why?
|
| Male | 15 | 2019 | 365249 | 0.020 |
Why?
|
| Infertility | 1 | 2019 | 654 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15471 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2015 | 540 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 10397 | 0.020 |
Why?
|
| Neurons | 1 | 2011 | 9524 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 552 | 0.020 |
Why?
|
| Thumb | 3 | 1984 | 232 | 0.020 |
Why?
|
| Replantation | 2 | 1984 | 145 | 0.020 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1970 | 32 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 2012 | 183 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 438 | 0.020 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 590 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2019 | 81892 | 0.020 |
Why?
|
| Cutis Laxa | 1 | 1970 | 29 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4265 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2014 | 587 | 0.020 |
Why?
|
| Autopsy | 1 | 2014 | 1013 | 0.020 |
Why?
|
| Models, Educational | 1 | 2012 | 375 | 0.020 |
Why?
|
| Incidence | 3 | 2014 | 21545 | 0.020 |
Why?
|
| Polyhydramnios | 1 | 2009 | 41 | 0.020 |
Why?
|
| Gestational Age | 2 | 2009 | 3610 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2012 | 548 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2010 | 186 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 796 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 744 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 169408 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1498 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 1266 | 0.020 |
Why?
|
| Minority Groups | 1 | 2015 | 1216 | 0.020 |
Why?
|
| Monosomy | 1 | 2007 | 52 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 22294 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 79 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2007 | 205 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15955 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 2507 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8888 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 22390 | 0.020 |
Why?
|
| Middle Aged | 6 | 2017 | 223740 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 362 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1515 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 3214 | 0.010 |
Why?
|
| Sample Size | 1 | 2008 | 848 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 3269 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2010 | 1531 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2784 | 0.010 |
Why?
|
| Decision Making | 1 | 2017 | 3952 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3925 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6901 | 0.010 |
Why?
|
| Internet | 1 | 2014 | 3112 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2007 | 708 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 18065 | 0.010 |
Why?
|
| Child, Preschool | 6 | 2012 | 42684 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2359 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8742 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40266 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 39394 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 769 | 0.010 |
Why?
|
| Amputation, Traumatic | 1 | 1980 | 135 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 13048 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 30266 | 0.010 |
Why?
|
| Finger Injuries | 1 | 1980 | 145 | 0.010 |
Why?
|
| Cryptorchidism | 1 | 1980 | 153 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 6213 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1979 | 155 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2009 | 2701 | 0.010 |
Why?
|
| Toes | 1 | 1979 | 209 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2055 | 0.010 |
Why?
|
| Fingers | 1 | 1980 | 512 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6085 | 0.010 |
Why?
|
| Adolescent | 5 | 2017 | 89247 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11262 | 0.010 |
Why?
|
| Testis | 1 | 1980 | 784 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41800 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 12873 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1979 | 829 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 16051 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1979 | 1097 | 0.010 |
Why?
|
| Rabbits | 1 | 1979 | 4774 | 0.010 |
Why?
|
| Graft Survival | 1 | 1984 | 3888 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22381 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2012 | 5956 | 0.010 |
Why?
|
| Infant | 3 | 2010 | 36541 | 0.010 |
Why?
|
| Micrognathism | 1 | 1970 | 64 | 0.010 |
Why?
|
| Genitalia | 1 | 1970 | 113 | 0.010 |
Why?
|
| Aged | 4 | 2012 | 171790 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 14199 | 0.000 |
Why?
|
| Child | 4 | 2010 | 80969 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 36861 | 0.000 |
Why?
|
| Transplantation, Autologous | 2 | 1980 | 2126 | 0.000 |
Why?
|
| Mice | 1 | 2011 | 82074 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 65485 | 0.000 |
Why?
|
| Blood Circulation | 1 | 1984 | 248 | 0.000 |
Why?
|
| Pedigree | 1 | 1970 | 4545 | 0.000 |
Why?
|
| Scrotum | 1 | 1980 | 118 | 0.000 |
Why?
|
| Methods | 1 | 1979 | 1066 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1980 | 727 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1980 | 822 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1984 | 6242 | 0.000 |
Why?
|
| Age Factors | 2 | 1984 | 18454 | 0.000 |
Why?
|
| Testicular Neoplasms | 1 | 1980 | 805 | 0.000 |
Why?
|
| Phenotype | 1 | 1970 | 16735 | 0.000 |
Why?
|
| Thrombosis | 1 | 1984 | 2956 | 0.000 |
Why?
|
| Prognosis | 1 | 1984 | 30044 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1984 | 54950 | 0.000 |
Why?
|